Back to comparisons

Comparison

Modafinil vs Synephrine (Bitter Orange)

FieldModafinilSynephrine (Bitter Orange)
Categorystimulantstimulant
Dose range100–200mg25–100mg
Half-life14h
Onset45min
EvidenceEVIDENCEAEVIDENCEB
Safety●●●○○●●●○○
Legal (US)USSchedule IVUSOTC
PubMed refs3200320

The comparison in plain English

Auto-generated from data

Modafinil and Synephrine (Bitter Orange) are both in the stimulant category respectively. Modafinil A eugeroic — a wakefulness-promoting compound — originally developed for narcolepsy. Synephrine (Bitter Orange) Citrus aurantium alkaloid.

Bottom line

Modafinil (evidence A, safety 3/5) has a weaker evidence base than Synephrine (Bitter Orange) (evidence B, safety 3/5). Modafinil has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Modafinil if

Modafinil is the better fit when your goal aligns with its mechanism (Inhibits dopamine reuptake via the dopamine transporter (DAT), increasing extracellular dopamine in the prefrontal cortex) and the dose range (100–200mg) suits your protocol. Half-life is 14h.

Choose Synephrine (Bitter Orange) if

Synephrine (Bitter Orange) is the better fit when your goal aligns with its mechanism (Selective beta-3 adrenergic agonist with some beta-1 and beta-2 activity) and the dose range (25–100mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →